Lymphovascular space invasion in endometrial carcinoma: A prognostic factor independent from molecular signature

Antonio Raffone, Antonio Travaglino, Diego Raimondo, Daniele Neola, Manuela Maletta, Angela Santoro, Luigi Insabato, Paolo Casadio, Francesco Fanfani, Gian Franco Zannoni, Fulvio Zullo, Renato Seracchioli, Antonio Mollo

Risultato della ricerca: Contributo in rivistaArticolo in rivista

Abstract

Background: The 2020 ESGO/ESTRO/ESP guidelines stratify the prognosis of endometrial carcinoma (EC) patients combining The Cancer Genome ATLAS (TCGA) molecular signature and pathological factors, including lymphovascular space invasion (LVSI). However, little is known about the prognostic independence of LVSI from molecular signature. Aim: To assess whether the prognostic value of LVSI is independent from the TCGA signature. Material and methods: A systematic review and meta-analysis was performed by searching 5 electronic databases from their inception to March 2021. All peer-reviewed studies reporting assessing LVSI as a prognostic factor independent from the TCGA groups in EC were included. Multivariate HRs with 95% confidence interval (CI) were pooled separately for overall survival (OS), disease-specific survival (DSS) and disease-free survival (DFS). The absence of LVSI was considered as a reference. In DFS analyses, locoregional and distant recurrence were separately considered for one study. Results: Six studies with 3331 patients were included in the systematic review and three studies with 2276 patients in the meta-analysis. LVSI showed a pooled multivariate HR of 1.818 (CI 95%, 1.378–2.399) for OS, 1.849 (CI 95%, 1.194–2.863) for DSS, 1.377 (CI 95%, 1.008–1.880) for DFS excluding one study, 1.651 (CI 95%, 1.044–2.611) for DFS additionally considering locoregional recurrence from one study, and 1.684 (CI 95%, 1.05–2.701) for DFS additionally considering distant recurrence from the same study. Conclusion: LVSI has a prognostic value independent of TCGA signature, as well as age and adjuvant treatment, increasing the risk of death of any cause, death due to EC and recurrent or progressive disease by 1.5–2 times.
Lingua originaleEnglish
pagine (da-a)192-197
Numero di pagine6
RivistaGynecologic Oncology
Volume165
DOI
Stato di pubblicazionePubblicato - 2022

Keywords

  • Cancer
  • Disease-Free Survival
  • Endometrial Neoplasms
  • Endometrium
  • Female
  • Humans
  • Neoplasm Invasiveness
  • Neoplasm Recurrence, Local
  • Neoplasm Staging
  • PROMISE
  • Prognosis
  • Retrospective Studies
  • Risk assessment
  • Treatment
  • Tumor

Fingerprint

Entra nei temi di ricerca di 'Lymphovascular space invasion in endometrial carcinoma: A prognostic factor independent from molecular signature'. Insieme formano una fingerprint unica.

Cita questo